Corporate Law Center symposium examines the changing administrative law landscape

The Corporate Law Center at the University of Cincinnati College of Law will host its 34th annual symposium, examining “The Changing Administrative Landscape: Cause for Business to Celebrate or Worry?”.  This day-long event will be held Friday, March 7, 2024, in Rm. 160 of the College of Law (2925 Campus Green Drive).

CLE:  4 CLE General + 1 Professional (OH); 5 CLE General (KY)

Registration: Registration is required. There is a $75 cost to attend, which includes the symposium, meals and reception.   

About the Symposium

The Corporate Law Center has brought together top corporate legal counsel, distinguished practitioners, and leading scholars to provide insightful discussions on recent developments in administrative law and their impact on business. Prominent experts will share their perspectives on how businesses can adapt to the evolving relationship between the courts, government agencies, and the corporate world.

Keynote Address

  • Lisa Heinzerling, Justice William J. Brennan Professor of Law, Georgetown Law Center, who will deliver the keynote address “Regulatory Uncertainty and the new Administrative Law”.

Panels + Panelists

Panel 1: Loper Bright & Friends – Good for Business?
  • Lisa Heinzerling, Justice William J. Brennan Professor of Law, Georgetown Law Center
  • Susan Whaley, Chief Legal Officer, Procter & Gamble
  • John Applegate, James L. Calamaras Professor of Law, Indiana University
  • Art McMahon, Partner, Taft
  • Thad Driscoll, EHS Senior Counsel at GE Aerospace
  • Moderator: Neil Taylor, Director, Corporate Law Center, UC Law
Panel 2: Corporate Fiduciary Duties After Corner Post
  • Bridget Dooling, Assistant Professor of Law, Moritz College of Law,  Ohio State University
  • Stephen Ewald, General Counsel, Chief Compliance Officer and Corporate Secretary, Medpace, Inc.
  • Beth Naylor, Partner, Frost, Brown Todd
  • Matt Miner, Executive Vice President and Global Chief Ethics and Compliance Officer, Walmart
  • Moderator: Kate Jackson, Associate Professor of Law, UC Law
Panel 3: Environmental Regulation after Ohio v. EPA
  • Bradford Mank,  James B. Helmer Professor of Law, UCLaw
  • Keith Bradley,  Partner, Squire, Patton Boggs
  • David Altman, President, Altman Newman
  • Moderator:  Neil Taylor, Director, Corporate Law Center, UC Law
Panel 4: The Future of SEC Enforcement after Jarkesy
  • David Stoelting, Senior Trial Counsel, SEC
  • David Lavan, Partner, Dinsmore & Shohl
  • Scott Young, Partner, Thompson Hine
  • Lynn Bai, Professor of Law, UC Law
  • Moderator: Michael Moeddel, Partner, Taft

First held in 1988, the Corporate Law Symposium is co-sponsored by the University of Cincinnati Law Review. This year, we are partnering with the Lindner College of Business and the Association of Corporate Counsel to further enrich the program.

Additionally, we are appreciative of our event sponsors: Procter and Gamble, Medpace, Dinsmore & Shohl, Altman Newman Co. LPA, Squire Patton Boggs, Thompson Hine LLP, and KMK Law.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.